• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺乳头状癌侵袭前沿的细胞极性/黏附丧失,一种新的淋巴结转移预测因子;上皮-间质转化的可能形态学指标。

Loss of cellular polarity/cohesiveness in the invasive front of papillary thyroid carcinoma, a novel predictor for lymph node metastasis; possible morphological indicator of epithelial mesenchymal transition.

机构信息

Department of Human Pathology, Wakayama Medical University, Kimiidera, Wakayama Japan.

出版信息

J Clin Pathol. 2011 Apr;64(4):325-9. doi: 10.1136/jcp.2010.083956. Epub 2011 Feb 4.

DOI:10.1136/jcp.2010.083956
PMID:21296795
Abstract

BACKGROUND

Loss of cellular polarity/cohesiveness (LOP/C) in the invasive front of papillary thyroid carcinoma (PTC) results in a high recurrence risk of PTC.

AIMS

To investigate the immunohistochemical features of LOP/C in PTC and to show that this feature is linked to a high association of lymph node metastasis (LNM) at surgery and tumour recurrence.

METHODS

The degree of LOP/C of the PTCs was evaluated histologically using a cut-off value of 20% and the immunohistochemical features of LOP/C were analysed using immunohistochemical staining for E-cadherin, β-catenin and vimentin. The relationship between the LOP/C and the other clinicopathological parameters was analysed.

RESULTS

43 cases of PTC with LOP/C (≥20%) were selected and 27 cases with LOP/C (<20%) were included as control tumours. 11/44 cases (25%) were observed to develop recurrence, LNM or distant metastasis at an average follow-up of 31 months. Less expression of E-cadherin and aberrant localisation of β-catenin and vimentin were observed in PTC tumour cells with LOP/C. LOP/C (≥20%) was significantly correlated with extrathyroid invasion (r=0.336, p=0.003), advanced tumour stage (r=0.275, p=0.017), LNM (r=0.389, p<0.001) and recurrence after surgery (r=0.302, p=0.036). Both extrathyroid invasion and LOP/C were independent significant predictors of LNM.

CONCLUSIONS

LOP/C may be a useful morphological feature of epithelial mesenchymal transition under H&E observation, and it is an important indicator of lymph node metastasis and aggressive clinical behaviour of PTC.

摘要

背景

甲状腺乳头状癌(PTC)侵袭前沿的细胞极性/黏附丧失(LOP/C)导致 PTC 复发风险增加。

目的

研究 PTC 中 LOP/C 的免疫组织化学特征,并表明该特征与手术时淋巴结转移(LNM)和肿瘤复发的高关联性相关。

方法

使用 20%的截断值评估 PTC 的 LOP/C 程度,并使用 E-钙黏蛋白、β-连环蛋白和波形蛋白的免疫组织化学染色分析 LOP/C 的免疫组织化学特征。分析 LOP/C 与其他临床病理参数之间的关系。

结果

选择 43 例 LOP/C(≥20%)的 PTC 病例,并纳入 27 例 LOP/C(<20%)的对照肿瘤。在平均 31 个月的随访中,11/44 例(25%)患者发生复发、LNM 或远处转移。在具有 LOP/C 的 PTC 肿瘤细胞中,E-钙黏蛋白的表达减少,β-连环蛋白和波形蛋白的局部定位异常。LOP/C(≥20%)与甲状腺外侵犯(r=0.336,p=0.003)、肿瘤晚期(r=0.275,p=0.017)、LNM(r=0.389,p<0.001)和术后复发(r=0.302,p=0.036)显著相关。甲状腺外侵犯和 LOP/C 均是 LNM 的独立显著预测因子。

结论

LOP/C 可能是 H&E 观察下上皮间质转化的有用形态特征,是 PTC 淋巴结转移和侵袭性临床行为的重要指标。

相似文献

1
Loss of cellular polarity/cohesiveness in the invasive front of papillary thyroid carcinoma, a novel predictor for lymph node metastasis; possible morphological indicator of epithelial mesenchymal transition.甲状腺乳头状癌侵袭前沿的细胞极性/黏附丧失,一种新的淋巴结转移预测因子;上皮-间质转化的可能形态学指标。
J Clin Pathol. 2011 Apr;64(4):325-9. doi: 10.1136/jcp.2010.083956. Epub 2011 Feb 4.
2
[Relationship between activated STAT3 protein and epithelial-mesenchymal transition in papillary thyroid carcinoma].[甲状腺乳头状癌中活化的信号转导和转录激活因子3蛋白与上皮-间质转化的关系]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2013 Nov;27(22):1265-8.
3
Aberrant expression of nuclear vimentin and related epithelial-mesenchymal transition markers in nasopharyngeal carcinoma.核层粘连蛋白异常表达及相关上皮-间充质转化标志物在鼻咽癌中的表达。
Int J Cancer. 2012 Oct 15;131(8):1863-73. doi: 10.1002/ijc.27467. Epub 2012 Mar 15.
4
Retinoid X receptor γ up-regulation is correlated with dedifferentiation of tumor cells and lymph node metastasis in papillary thyroid carcinoma.维 A 酸 X 受体 γ 的上调与甲状腺乳头状癌中肿瘤细胞去分化和淋巴结转移相关。
Pathol Int. 2011 Mar;61(3):109-15. doi: 10.1111/j.1440-1827.2010.02623.x. Epub 2010 Dec 8.
5
Twist1 regulates the epithelial-mesenchymal transition via the NF-κB pathway in papillary thyroid carcinoma.Twist1通过核因子κB通路调控甲状腺乳头状癌中的上皮-间质转化。
Endocrine. 2016 Mar;51(3):469-77. doi: 10.1007/s12020-015-0714-7. Epub 2015 Aug 20.
6
High expression and localization of β-catenin and epidermal growth factor receptor identify high risk papillary thyroid carcinoma patients.β-连环蛋白和表皮生长因子受体的高表达和定位可识别高风险甲状腺乳头状癌患者。
Exp Mol Pathol. 2018 Oct;105(2):181-189. doi: 10.1016/j.yexmp.2018.08.001. Epub 2018 Aug 2.
7
Papillary carcinoma of the thyroid in Japan: subclassification of common type and identification of low risk group.日本甲状腺乳头状癌:常见类型的亚分类及低风险组的识别
J Clin Pathol. 2004 Oct;57(10):1041-6. doi: 10.1136/jcp.2004.017889.
8
Loss of cellular polarity/cohesiveness in the invasive front of papillary thyroid carcinoma and periostin expression.甲状腺乳头状癌浸润前沿的细胞极性/黏附性丧失与骨膜蛋白表达
Cancer Lett. 2009 Aug 28;281(2):188-95. doi: 10.1016/j.canlet.2009.02.043. Epub 2009 Mar 24.
9
Strong expression of HBME-1 associates with high-risk clinicopathological factors of papillary thyroid carcinoma.HBME-1的强表达与甲状腺乳头状癌的高危临床病理因素相关。
Pathol Oncol Res. 2015 Jul;21(3):735-42. doi: 10.1007/s12253-014-9883-6. Epub 2015 Jan 11.
10
[Clinicopathological factors in risk prediction of lymph node metastasis in papillary thyroid carcinoma].[甲状腺乳头状癌淋巴结转移风险预测中的临床病理因素]
Zhonghua Yi Xue Za Zhi. 2014 Dec 16;94(46):3637-41.

引用本文的文献

1
BRAF V600E and TERT promoter mutations and their impact on recurrent papillary thyroid carcinoma progression.BRAF V600E和端粒酶逆转录酶(TERT)启动子突变及其对复发性乳头状甲状腺癌进展的影响。
Endocr Connect. 2025 Jul 30;14(7). doi: 10.1530/EC-25-0116. Print 2025 Jul 1.
2
Associations between pathological features and radioactive iodine-refractory recurrent papillary thyroid carcinoma: with mutation analysis using recurrent samples.病理特征与放射性碘难治性复发性乳头状甲状腺癌之间的关联:基于复发性样本的突变分析
BMC Endocr Disord. 2025 May 20;25(1):134. doi: 10.1186/s12902-025-01954-9.
3
Regressed Papillary Thyroid Carcinoma with Anaplastic Transformation into Lymph Node Metastasis: Case Report with Review of the Literature.
伴有间变性转化至淋巴结转移的退缩性乳头状甲状腺癌:病例报告及文献复习
Diagnostics (Basel). 2025 Feb 21;15(5):523. doi: 10.3390/diagnostics15050523.
4
Respiratory Syncytial Virus Infection Does Not Induce Epithelial-Mesenchymal Transition.呼吸道合胞病毒感染不会诱导上皮-间充质转化。
J Virol. 2023 Jul 27;97(7):e0039423. doi: 10.1128/jvi.00394-23. Epub 2023 Jun 20.
5
Endocrine disrupting and carcinogenic effects of decabromodiphenyl ether.十溴二苯醚的内分泌干扰和致癌作用。
Front Endocrinol (Lausanne). 2023 Jun 2;14:1183815. doi: 10.3389/fendo.2023.1183815. eCollection 2023.
6
Osteopontin Expression in Thyroid Cancer: Deciphering EMT-Related Molecular Mechanisms.骨桥蛋白在甲状腺癌中的表达:解读与上皮-间质转化相关的分子机制
Biomedicines. 2021 Oct 1;9(10):1372. doi: 10.3390/biomedicines9101372.
7
Ultrasound Echogenicity of Papillary Thyroid Cancer Is Affected by Tumor Growth Patterns and Tumor Fibrosis.甲状腺癌的超声回声特征受肿瘤生长模式和肿瘤纤维化的影响。
In Vivo. 2021 May-Jun;35(3):1633-1640. doi: 10.21873/invivo.12421.
8
Molecular Pathology of Non-familial Follicular Epithelial-Derived Thyroid Cancer in Adults: From RAS/BRAF-like Tumor Designations to Molecular Risk Stratification.成人非家族性滤泡上皮来源甲状腺癌的分子病理学:从 RAS/BRAF 样肿瘤分类到分子风险分层。
Endocr Pathol. 2021 Mar;32(1):44-62. doi: 10.1007/s12022-021-09666-1. Epub 2021 Mar 2.
9
Updates in the Pathologic Classification of Thyroid Neoplasms: A Review of the World Health Organization Classification.甲状腺肿瘤病理学分类的更新:对世界卫生组织分类的综述。
Endocrinol Metab (Seoul). 2020 Dec;35(4):696-715. doi: 10.3803/EnM.2020.807. Epub 2020 Dec 2.
10
The effect of implementing pre-surgical ultrasound-guided fine-needle aspiration biopsy on thyroid surgery, a 6-year interrupted time series analysis in Qilu Hospital of Shandong University.山东大学齐鲁医院实施术前超声引导下细针穿刺活检对甲状腺手术的影响:一项6年中断时间序列分析
Gland Surg. 2020 Oct;9(5):1716-1723. doi: 10.21037/gs-20-348.